Variable | Drug reatment | Placebo Treatment | P value |
---|---|---|---|
Number of patients | 80 | 68 | |
Age (years) | 69.5 ± 5.6 | 68.5 ± 5.3 | 0.450 |
I-PSS | 16.8 ± 4.9 | 19.3 ± 5.0 | 0.002 |
Storage symptom score | 10.3 ± 3.4 | 10.7 ± 3.4 | 0.007 |
Voiding symptom score | 6.5 ± 2.4 | 8.6 ± 2.3 | 0.003 |
QoL score | 3.1 ± 0.6 | 3.8 ± 1.0 | 0.005 |
Serum PSA (ng/ml) | 2.2 ± 1.7 | 2.1 ± 1.6 | 0.355 |
Prostate volume (ml) | 39.4 ± 19.4 | 41.4 ± 20.1 | 0.235 |
Qmax | 14.0 ± 2.4 | 16.5 ± 2.6 | 0.043 |
24-h drinking volume (ml) | 1465.4 ± 624.8 | 1505.4 ± 610.8 | 0.356 |
4-h before bedtime drinking volume (ml) | 115.8 ± 100.9 | 106.6 ± 97.9 | 0.452 |
Frequency of nocturia | 2.8 ± 0.7 | 3.0 ± 0.6 | 0.306 |
Frequency of daytime urination | 7.5 ± 2.6 | 8.1 ± 2.6 | 0.002 |
Maximum urination volume (ml) | 372.8 ± 103.3 | 302.8 ± 119.3 | 0.007 |
Morning urine volume (ml) | 280.5 ± 111.7 | 259.5 ± 100.7 | 0.003 |
24-h total urine volume (ml) | 1965.5 ± 623.5 | 1896.5 ± 637.5 | 0.231 |
Nocturnal urine volume (ml) | 800.7 ± 323.0 | 845.7 ± 303.5 | 0.056 |